Grovepoint Capital

Grovepoint Capital
Industry	Private equity
Founded	2010
Founder	; Bradley Fried
Headquarters	London, NW1; United Kingdom
Website	grovepoint.co.uk

Grovepoint Capital is a private equity firm headquartered in London, United Kingdom.^[1] It has additional offices in Israel.^[1] It was co-founded by and Bradley Fried in 2010.^[1]^[2]^[3] In 2013, it acquired Algatechnologies, an Israeli biotech start-up, for $15 million-$20 million.^[3]

References[]

^ ^a ^b ^c "Company Overview of Grovepoint Capital LLP". Bloomberg Business. Retrieved October 16, 2015.
^ Denham, Annabelle (November 18, 2013). "Startup springboks who let the idea come to them". City A.M. Retrieved October 16, 2015.
^ ^a ^b Bar-Eli, Avi (February 10, 2013). "U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies: Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging". Haaretz. Retrieved October 16, 2015.

This London-related article is a stub. You can help Wikipedia by .

[bloomberg-1] "Company Overview of Grovepoint Capital LLP". Bloomberg Business. Retrieved October 16, 2015.

[startupspring-2] Denham, Annabelle (November 18, 2013). "Startup springboks who let the idea come to them". City A.M. Retrieved October 16, 2015.

[ukinvest-3] Bar-Eli, Avi (February 10, 2013). "U.K. Investment Firm Snaps Up Israeli Start-up Algatechnologies: Grovepoint Capital is paying an estimated $15 million to $20 million for the company, which fights the effects of aging". Haaretz. Retrieved October 16, 2015.

[1]

[2]

[3]